Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Vertex Pharmaceuticals (NQ: VRTX )

495.61 +7.27 (+1.49%)
Streaming Delayed Price Updated: 1:40 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
58 59 Next >
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions. 
Via Investor's Business Daily
Exposures Product Safety
Is NASDAQ:VRTX suited for quality investing?
Reasonable growth and debt and a high ROIC for VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX). 
Via Chartmill
3 Top Healthcare Stocks Defying the Bear Market
Revenue at all three companies improved last quarter, and their share prices have followed suit. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Vertex Researchers Awarded 2024 Breakthrough Prize in Life Sciences
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Could These Be Vertex Pharmaceuticals' Most Promising Candidates?
The biotech has no shortage of promising pipeline programs. 
Via The Motley Fool
Expert Ratings for Vertex Pharmaceuticals
Via Benzinga
Better Bull Market Buy: CRISPR vs. Medtronic Stock
Investors may look for growth stocks ahead of the next bull market. 
Via The Motley Fool
A Bull Market Is (Still) Coming: Here Are 3 Spectacular Stocks to Buy Sooner Rather Than Later
These stocks should be even bigger winners than they already are when a new bull market takes hold. 
Via The Motley Fool
3 Unstoppable Growth Stocks to Buy Right Now
These healthcare stocks show no signs of slowing down. 
Via The Motley Fool
1 Top Pharma Growth Stock to Buy Today and Hold Forever
Vertex's encouraging mix of recurring revenue and growth make it a leader. 
Via The Motley Fool
2 Top Biotech Stocks to Buy in September
There is rarely a bad time to buy stocks with massive upside potential. 
Via The Motley Fool
September Rally? 3 Stocks to Buy Before Liftoff
September has the reputation as the worst performing month of the year, but these are stocks to buy now in anticipation of the rally to come. 
Via InvestorPlace
Looking Into Vertex Pharmaceuticals's Recent Short Interest
Via Benzinga
3 Must-Know Tricks for Investing in Big Pharma Stocks
Using these tricks will help you appreciate where and when to invest. 
Via The Motley Fool
CRSP Stock Alert: What to Know as CRISPR Therapeutics Co-Founder Steps Down
With CRISPR Therapeutics announcing the departure of its co-founder, investors are also walking for the exits on CRSP stock. 
Via InvestorPlace
Healthcare Portfolio: A Mixed Market Looking for Value
Many healthcare stocks may be defensive in nature but if you are overweight the basic plays like the XLV or biotech funds like the Fidelity Biotechnology Fund you are trailing the market over the past... 
Via Talk Markets
3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains
These biotech stocks to buy and hold offer tremendous upside blending long-term potential with healthcare advances. 
Via InvestorPlace
With a Prediction for a 70% Gain, Is Wall Street Too Optimistic About This Biotech Stock?
Big news could come in December and in March. 
Via The Motley Fool
The 3 Best Biotech Stocks to Buy Now: September 2023
With the biotech sector looking poised to continue its rally further, investors would do well to buy these stocks to capitalize. 
Via InvestorPlace
5 Surefire Stocks That Can Build Generational Wealth in 20 Years
Time is a trusted ally when you're invested in innovative businesses with sustained competitive advantages. 
Via The Motley Fool
2 Spectacular Growth Stocks You Can Buy in September With No Hesitation
There's no need for any anxiety with investing in these great stocks. 
Via The Motley Fool
The 3 Most Promising Biotech Stocks to Own Now
These top biotech stock picks with high and leading growth potential are must-owns for investors looking for high upside potential. 
Via InvestorPlace
Vertex to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference on September 13
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Vertex Appoints E. Morrey Atkinson, Ph.D., to EVP and Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations
From Vertex Pharmaceuticals Incorporated
Via Business Wire
3 Top Growth Stocks I'd Buy Right Now Without Hesitation
These drugmakers are all leaders in their respective niches. 
Via The Motley Fool
Ross Stores, Vertex Pharmaceuticals And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years
Via Benzinga
Got $600? Here are 3 No-Brainer Stocks You Absolutely Must Buy
You don't need a lot of money to make money when you invest in these no-brainer stocks at the start your investing career 
Via InvestorPlace
2 No-Brainer Biotech Stocks to Buy Right Now
These two companies make a compelling case for a high price. 
Via The Motley Fool
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
58 59 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.